Free Daily Podcast Summary
FLASCO OncoPod: Daily Summaries Delivered
by Florida Society of Clinical Oncology
The FLASCO OncoPod is a podcast series that brings you engaging interviews and conversations with oncology champions and thought leaders. Each episode explores important topics in cancer care, from the latest clinical advancements to FLASCO events and initiatives. Whether it’s discussing groundbreaking research, policy updates, or sharing personal stories from members, the OncoPod keeps oncology professionals informed and connected. It’s your go-to source for staying up-to-date on FLASCO’s efforts to support and strengthen the oncology community across Florida.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- 3 days ago18 min
Empowering the Next Generation of Oncology: SOFLOH & the Fellows and Residents Training Program
Join FLASCO OncoPod for a special conversation with Dr. Jani and Dr. Rosas as they highlight the South Florida Fellows Hematology Oncology (SOFLOH) initiative and the upcoming FLASCO Fellows & Residents Training Program.In this episode, our guests discuss the importance of mentorship, professional development, and meaningful connections for the next generation of hematology and oncology professionals. Learn more about SOFLOH's mission to support fellows and residents, the opportunities available through FLASCO, and what attendees can look forward to at this year's training program.Whether you're a current fellow, resident, or physician passionate about supporting the future of oncology, this episode offers a closer look at the people and programs helping shape the next generation of cancer care.
- 3 days ago20 min
The Nuance in mTNBC | Part 3: Toxicity, Delivery, and the Rest of the Journey
Selecting an effective treatment is only the beginning of managing metastatic triple-negative breast cancer (mTNBC). In this episode of The Nuance in mTNBC, Dr. Edgardo Santos and Dr. Victoria Rizk examine the practical challenges of delivering and sustaining therapy, from treatment initiation through disease progression. Using a longitudinal patient case and findings from a FLASCO clinician survey, faculty discuss toxicity prevention and management, dose modifications, and the clinical considerations surrounding antibody-drug conjugate (ADC) therapy. The conversation explores treatment scheduling, insurance authorization, financial barriers, and strategies to support treatment continuity. Faculty also address rebiopsy, biomarker reassessment, therapeutic sequencing, and the importance of timely clinical trial referrals to help optimize care throughout the patient's treatment journey. This content has been created independently and solely by FLASCO. FLASCO would like to recognize our Elite Sponsor, Gilead Sciences, Inc.
- 1 weeks ago15 min
The Nuance in mTNBC | Part 2: The Patient the Trial Did Not Enroll
How should clinicians approach metastatic triple-negative breast cancer (mTNBC) when a patient's treatment history does not align with the populations studied in clinical trials? In this episode of The Nuance in mTNBC, Dr. Edgardo Santos and Dr. Victoria Rizk explore the challenges of managing patients who experience recurrence following neoadjuvant immunotherapy and chemotherapy. Through case-based discussion and insights from a FLASCO clinician survey, faculty examine the significance of treatment-free intervals, prior immunotherapy exposure, germline BRCA mutations, and the evolving first-line treatment landscape. The conversation also addresses the limitations of available clinical evidence, considerations for immunotherapy rechallenge, and individualized treatment strategies for patients with comorbidities, reduced performance status, or preferences that may limit therapeutic options. This content has been created independently and solely by FLASCO. FLASCO would like to recognize our Elite Sponsor, Gilead Sciences, Inc.
- 2 weeks ago15 min
The Nuance in mTNBC | Part 1: Where the Answers Split
Treatment decisions in metastatic triple-negative breast cancer (mTNBC) are becoming increasingly complex as new therapeutic options reshape the first-line landscape. In this episode of The Nuance in mTNBC, Dr. Edgardo Santos and Dr. Victoria Rizk examine the clinical decisions surrounding PD-L1 expression, germline BRCA mutations, and the evolving role of antibody-drug conjugates (ADCs). Drawing on insights from a FLASCO clinician survey, the discussion explores biomarker testing, treatment selection while results are pending, and the implications of recent first-line sacituzumab govitecan approvals. Faculty review findings from the ASCENT-03 and ASCENT-04 trials, address areas of clinical uncertainty, and discuss how emerging evidence influences shared decision-making when overall survival data remain immature.This content has been created independently and solely by FLASCO. FLASCO would like to recognize our Elite Sponsor, Gilead Sciences, Inc.
- Aug 3, 202623 min
Drew Piers on Advocacy, Storytelling & Shaping the Future of Cancer Care
In this episode of the FLASCO OncoPod, Drew Piers, President of Sachs Media, explores the powerful role advocacy, storytelling, and strategic communications play in advancing cancer care beyond the clinic. Drawing on years of experience working alongside healthcare organizations and oncology professionals, Drew discusses how trusted clinician voices can influence public policy, improve patient access to care, and strengthen public confidence in the healthcare system. Listeners will gain practical insights into communicating complex healthcare issues with clarity, combining patient stories with evidence-based data, and engaging policymakers in meaningful ways that drive positive change. Whether through community outreach, media engagement, or legislative advocacy, this episode highlights how every oncology professional can help shape the future of cancer care through authentic, patient-centered communication.Sachs Health INFLUENCE INDEX: https://sachsmedia.com/wp-content/uploads/2026/05/SachsHEALTH-Influence-Index-2026.pdf
- Jul 27, 202629 min
The Evolving Management of Hepatocellular Carcinoma: Prevention, Multidisciplinary Care, and Emerging Therapies
Hepatocellular carcinoma (HCC) continues to present unique challenges for oncology teams, requiring coordinated multidisciplinary care and an evolving understanding of both liver disease and cancer management. In this episode of the FLASCO OncoPod, Dr. Beau Bosko Toskich, MD, FSIR, Professor of Radiology, Medical Oncology, and Radiation Oncology and Director of Interventional Oncology at Mayo Clinic Comprehensive Cancer Center, provides a comprehensive overview of the modern HCC treatment landscape.Dr. Toskich discusses the changing epidemiology of hepatocellular carcinoma, emphasizing the growing impact of metabolic-associated liver disease, the importance of early detection and surveillance, and opportunities for disease prevention. He explores how multidisciplinary collaboration—including hepatology, surgery, interventional radiology, medical oncology, and radiation oncology—has transformed patient care, while highlighting the expanding role of locoregional therapies, immunotherapy, transplant evaluation, and emerging combination treatment strategies. Listeners will gain practical insights into patient selection, downstaging approaches, and the latest advances that are reshaping outcomes for patients with HCC.Whether you routinely manage liver cancer or simply want to stay current on one of oncology's fastest-evolving disease states, this episode offers valuable clinical perspectives on delivering personalized, multidisciplinary care for patients with hepatocellular carcinoma.
- Jul 20, 202621 min
The Evolving Role of Community Oncology: Delivering Academic-Level Cancer Care Close to Home
In this episode of the FLASCO OncoPod, Dr. McDonough moderates a discussion with Dr. Wenk, Dr. Glick, and Dr. Patel, of Florida Cancer Specialists & Research Institute on the evolving role of community oncology and how today's practices are delivering academic-level cancer care closer to home.Together, they explore how community oncology has transformed over the past decade, highlighting advances in precision medicine, immunotherapy, clinical research, and innovative care models. The conversation examines how large practice networks maintain consistent, high-quality care while expanding access to cutting-edge therapies and clinical trials for patients across diverse communities.From scaling innovation across a statewide network to bringing academic-level expertise closer to home, this episode offers valuable insights into the future of oncology care and the increasingly vital role community oncology plays in advancing cancer treatment, research, and patient outcomes.
- Jul 20, 202620 min
Part 4, Advancing Biomarker-Driven Care Through Optimized IHC Testing: Practical Insights on IHC Testing Across Tumor Types
In this episode of the FLASCO OncoPod, host Dr. Edgardo Santos, President of the Florida Society of Clinical Oncology (FLASCO), leads a multidisciplinary discussion on the evolving role of immunohistochemistry (IHC) in precision oncology. Joined by Dr. Lamees Saeed (Tampa General Hospital Cancer Institute), Dr. Jesus Fabregas (Memorial Cancer Institute), Dr. Ana Sandoval (Herbert Wertheim Cancer Institute at Baptist Health South Florida), and Dr. Nathalie McKenzie (AdventHealth Cancer Institute), the panel explores how IHC has evolved from a diagnostic tool into a critical component of biomarker-driven treatment selection.In part 4, the panel examines the real-world barriers that continue to affect IHC testing, including variability in reflex testing, pathology workflows, tissue stewardship, and reporting consistency. Experts share practical strategies for improving communication between oncologists and pathologists, streamlining testing protocols, and ensuring patients receive timely, comprehensive biomarker evaluation. Looking ahead, the discussion explores how artificial intelligence, digital pathology, electronic medical record integration, and automated clinical trial matching may transform precision oncology while reinforcing that multidisciplinary collaboration remains essential to delivering high-quality, personalized cancer care. The episode concludes with key takeaways clinicians can implement to strengthen biomarker-driven decision-making in their own practices.This podcast is being sponsored by Daiichi Sankyo.
Get FLASCO OncoPod summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Listeners also like.
INTERLUDE: Cancer Stories with Dr. Teplinsky
Eleonora Teplinsky
Out of the Gray (Gy) - Standard Imaging
Conversations with experts in radiation oncology exploring advancements in technology, research, and clinical practice.
Thrive Through and Beyond Cancer
Season Johnson
The Dr Pompa Podcast
A doctor discusses health, faith, and personal growth through conversations with experts in wellness and spirituality.
Frankly Speaking About Family Medicine
Discusses current topics and developments in primary care and family medicine.
BILFPOD
Conversations with business leaders and influencers explore their personal and professional lives through recurring themed segments.
Red Pill Your Healthcast
Two healthcare providers discuss overlooked health issues and empower listeners to make informed decisions for their families.
Data & Science with Glen Wright Colopy
Discusses healthcare technology with experts, focusing on data science and engineering innovations in clinical applications.
Our Skin: A Personal Discovery Podcast
People share personal experiences with skin conditions like psoriasis and HS, discussing diagnosis, treatment, and living fully despite challenges.
hol+ with Dr. Taz MD | The Future of Medicine is Holistic
Explores holistic health by connecting physical, mental, and emotional factors like hormones, inflammation, and stress with expert discussions.
hol+ with Dr. Taz MD | The Future of Medicine is Holistic
A physician explores holistic health through the interconnected physical, mental, emotional, energetic, and social dimensions of wellness.
Health Optimization Medicine Podcast
Experts discuss science-based strategies for health optimization, performance, and human potential through targeted interventions.
About FLASCO OncoPod
The FLASCO OncoPod is a podcast series that brings you engaging interviews and conversations with oncology champions and thought leaders. Each episode explores important topics in cancer care, from the latest clinical advancements to FLASCO events and initiatives. Whether it’s discussing groundbreaking research, policy updates, or sharing personal stories from members, the OncoPod keeps oncology professionals informed and connected. It’s your go-to source for staying up-to-date on FLASCO’s efforts to support and strengthen the oncology community across Florida.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from FLASCO OncoPod in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's FLASCO OncoPod daily summary?
It's a free AI-powered email that summarizes new episodes of FLASCO OncoPod as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the FLASCO OncoPod podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official FLASCO OncoPod product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Florida Society of Clinical Oncology.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
What topics does FLASCO OncoPod cover?
FLASCO OncoPod covers topics including Business, Medicine, Fitness, Health & Fitness, Non-Profit. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting FLASCO OncoPod summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.